Format

Send to

Choose Destination
Trends Microbiol. 2013 Jun;21(6):261-4. doi: 10.1016/j.tim.2013.03.006.

How academic labs can approach the drug discovery process as a way to synergize with big pharma.

Author information

1
Department of Molecular Medicine, University of Padua, Padua, Italy. arianna.loregian@unipd.it

Abstract

While the pharmaceutical industry is facing highly challenging times, the academic drug discovery sector has the potential to contribute meaningfully to the discovery of novel drug targets and to the development of new mode-of-action therapeutics against a range of diseases, including rare and neglected diseases.

PMID:
23731493
DOI:
10.1016/j.tim.2013.03.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center